New Haven, Conn. While the rate of in-hospital and 30-day mortality has decreased, the number of heart failure patients being readmitted to the hospital or discharged to a skilled nursing facility has increased, Yale School of Medicine researchers report in the June 2 issue of the Journal of the American Medical Association (JAMA).‘As clinicians, [...]
SAN DIEGO, CA (MARKET WIRE) 05/21/10 Marshall Edwards, Inc., (NASDAQ: MSHL). An abstract titled "A phase II study of oral phenoxodiol in castrate and non-castrate prostate cancer patients with associated cytokine changes" by Dr Kevin Kelly at the Yale School of Medicine Department of Medical Oncology, is now available at www.asco.org [...]
Apr. 28NEW HAVEN Patients want to know if their doctor is being given gifts by drug-makers or other companies, according to a Yale School of Medicine study issued Tuesday."Financial ties between clinicians, researchers and private companies continue to be a contentious issue among politicians, the media and physician groups," Dr. Cary Gross, associate professor [...]
New Haven, Conn Most patients and research subjects believe that the financial ties their clinicians and researchers have with private companies should be disclosed, according to findings published in Archives of Internal Medicine by researchers at Yale School of Medicine.‘Financial ties between clinicians, researchers and private companies continue to be a contentious issue among [...]
New Haven, Conn. On March 13, the Yale School of Medicine sent its second medical relief team to Haiti. The focus this time was less on emergency trauma such as crush injuries, and more on the long-term medical problems that continue to plague Haiti in the aftermath of the earthquake.The team worked at Hopital [...]
9 February 2010 – US biotechnology company Cara Therapeutics Inc reported yesterday encouraging data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845.The 46-patient, Phase II, multi-centre, double-blind, placebo-controlled study was conducted at eight hospitals in the US and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted [...]
SAN CARLOS, Calif., Nov. 30 /PRNewswire-FirstCall/ Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer. Dr. Masuoka will report directly to Nektar’s President and Chief Executive Officer, Howard W. Robin. "Lorianne’s outstanding leadership and highly effective clinical development strategies have been [...]
New Haven, Conn. – Dr. Robert J. Alpern is about to begin his second five-year term as dean of the Yale School of Medicine.With over 1,000 students, almost 2,000 faculty and a budget approaching $1 billion, the enterprise over which Alpern presides is by far the largest of the University’s graduate programs. It is also [...]
New Haven, Conn. – Before 500 invited guests and elected officials, and with many cancer survivors and their families looking on, the new Smilow Cancer Hospital at Yale-New Haven was formally dedicated at a ceremony on Oct. 21, launching what many hope will be a new era that seamlessly merges cutting-edge research, advanced cancer treatment [...]
